Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients. / Kragstrup, J; Shijie, Z; Mosekilde, L; Melsen, F.

In: Calcified Tissue International, Vol. 45, No. 6, 12.1989, p. 337-41.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kragstrup, J, Shijie, Z, Mosekilde, L & Melsen, F 1989, 'Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients', Calcified Tissue International, vol. 45, no. 6, pp. 337-41. https://doi.org/10.1007/BF02556003

APA

Kragstrup, J., Shijie, Z., Mosekilde, L., & Melsen, F. (1989). Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients. Calcified Tissue International, 45(6), 337-41. https://doi.org/10.1007/BF02556003

Vancouver

Kragstrup J, Shijie Z, Mosekilde L, Melsen F. Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients. Calcified Tissue International. 1989 Dec;45(6):337-41. https://doi.org/10.1007/BF02556003

Author

Kragstrup, J ; Shijie, Z ; Mosekilde, L ; Melsen, F. / Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients. In: Calcified Tissue International. 1989 ; Vol. 45, No. 6. pp. 337-41.

Bibtex

@article{b3ff73c6d92446b3b6dc36635c613ee1,
title = "Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients",
abstract = "The purpose of this histomorphometric study of iliac bone biopsies from 10 postmenopausal osteoporotic patients was to describe the effects of sodium fluoride (combined with calcium and vitamin D) on remodeling in cortical bone after 6 months and after 5 years of treatment. Biopsies had been fixed in absolute methanol, embedded undecalcified in methylmetacrylate, and cut on a heavyduty microtome. The therapy had no effect on the thickness of cortical bone in the iliac crest but increased the porosity slightly. It had no statistically significant effect on depth of resorption or thickness of new walls formed at remodeling sites but treatment increased the fraction of osteons undergoing remodeling in cortical bone. After 6 months of treatment, the increase was due to an enhanced activation of new remodeling sites, but in biopsies taken after 5 years of treatment, some degree of mineralization defect was observed and the duration of the remodeling cycle appeared to be prolonged. The mechanism underlying this qualitative change in the response to treatment is unknown, and it is unclear whether the mineralization defect may be prevented by, e.g., an altered supplementation of vitamin D or calcium.",
keywords = "Aged, Bone Regeneration/drug effects, Bone Resorption/pathology, Bone and Bones/drug effects, Calcium/pharmacology, Female, Humans, Middle Aged, Osteoporosis/pathology, Sodium Fluoride/pharmacology, Vitamin D/pharmacology",
author = "J Kragstrup and Z Shijie and L Mosekilde and F Melsen",
year = "1989",
month = dec,
doi = "10.1007/BF02556003",
language = "English",
volume = "45",
pages = "337--41",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer",
number = "6",

}

RIS

TY - JOUR

T1 - Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodeling in osteoporotic patients

AU - Kragstrup, J

AU - Shijie, Z

AU - Mosekilde, L

AU - Melsen, F

PY - 1989/12

Y1 - 1989/12

N2 - The purpose of this histomorphometric study of iliac bone biopsies from 10 postmenopausal osteoporotic patients was to describe the effects of sodium fluoride (combined with calcium and vitamin D) on remodeling in cortical bone after 6 months and after 5 years of treatment. Biopsies had been fixed in absolute methanol, embedded undecalcified in methylmetacrylate, and cut on a heavyduty microtome. The therapy had no effect on the thickness of cortical bone in the iliac crest but increased the porosity slightly. It had no statistically significant effect on depth of resorption or thickness of new walls formed at remodeling sites but treatment increased the fraction of osteons undergoing remodeling in cortical bone. After 6 months of treatment, the increase was due to an enhanced activation of new remodeling sites, but in biopsies taken after 5 years of treatment, some degree of mineralization defect was observed and the duration of the remodeling cycle appeared to be prolonged. The mechanism underlying this qualitative change in the response to treatment is unknown, and it is unclear whether the mineralization defect may be prevented by, e.g., an altered supplementation of vitamin D or calcium.

AB - The purpose of this histomorphometric study of iliac bone biopsies from 10 postmenopausal osteoporotic patients was to describe the effects of sodium fluoride (combined with calcium and vitamin D) on remodeling in cortical bone after 6 months and after 5 years of treatment. Biopsies had been fixed in absolute methanol, embedded undecalcified in methylmetacrylate, and cut on a heavyduty microtome. The therapy had no effect on the thickness of cortical bone in the iliac crest but increased the porosity slightly. It had no statistically significant effect on depth of resorption or thickness of new walls formed at remodeling sites but treatment increased the fraction of osteons undergoing remodeling in cortical bone. After 6 months of treatment, the increase was due to an enhanced activation of new remodeling sites, but in biopsies taken after 5 years of treatment, some degree of mineralization defect was observed and the duration of the remodeling cycle appeared to be prolonged. The mechanism underlying this qualitative change in the response to treatment is unknown, and it is unclear whether the mineralization defect may be prevented by, e.g., an altered supplementation of vitamin D or calcium.

KW - Aged

KW - Bone Regeneration/drug effects

KW - Bone Resorption/pathology

KW - Bone and Bones/drug effects

KW - Calcium/pharmacology

KW - Female

KW - Humans

KW - Middle Aged

KW - Osteoporosis/pathology

KW - Sodium Fluoride/pharmacology

KW - Vitamin D/pharmacology

U2 - 10.1007/BF02556003

DO - 10.1007/BF02556003

M3 - Journal article

C2 - 2509023

VL - 45

SP - 337

EP - 341

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 6

ER -

ID: 324193319